AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 297: H109-H116, 2009. First published May 8, 2009; doi:10.1152/ajpheart.00968.2008
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/1/H109    most recent
00968.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Murray, D. B.
Right arrow Articles by Janicki, J. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, D. B.
Right arrow Articles by Janicki, J. S.

ETA selective receptor antagonism prevents ventricular remodeling in volume-overloaded rats

David B. Murray, Ronald McMillan, Gregory L. Brower, and Joseph S. Janicki

Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, South Carolina

Submitted 5 September 2008 ; accepted in final form 8 May 2009

The objective of this study was to investigate the ability of selective endothelin receptor subtype A (ETA) endothelin receptor antagonism (ETA) to prevent the acute myocardial remodeling process secondary to volume overload. Left ventricular tissue from sham-operated (Sham) and untreated (Fist), and TBC-3214 (Fist + ETA, 25 mg·kg–1·day–1)-treated fistula animals was analyzed for mast cell density, matrix metalloproteinase (MMP) activity, and extracellular collagen volume fraction (CVF) 1 and 5 days following the initiation of volume overload. Compared with Fist, ETA treatment prevented the increase in left ventricular mast cell density at 1 day and 5 days. Additionally, at 1 day postfistula, a substantial decrease in MMP-2 activity below Sham levels was observed following endothelin receptor antagonism (1.7 ± 0.7 vs. 0.3 ± 0.3 vs. 0.9 ± 0.2 arbitrary activity units, Fist vs. Fist + ETA vs. Sham, P ≤ 0.05). This same effect was also seen at 5 days postfistula (1.9 ± 0.3 vs. 0.5 ± 0.1 arbitrary activity units, Fist vs. Fist + ETA, P ≤ 0.05). The marked decrease in myocardial CVF seen in Fist hearts (0.7 ± 0.1 vs. 1.6 ± 0.1% myocardial area, Fist vs. Sham, P ≤ 0.05) was prevented by ETA (1.7 ± 0.1% Fist + ETA, P < 0.05 vs. Fist). This preservation of the collagen matrix was also present on day 5 in the TBC-treated group vs. the Fist group (1.0 ± 0.1 vs. 1.4 ± 0.1%, Fist vs. Fist + ETA, P ≤ 0.01). Furthermore, an 8-wk preventative treatment with ETA significantly attenuated the increase in left ventricular end systolic and diastolic volumes compared with untreated fistula hearts. In conclusion, the novel findings of this study indicate that the activation of cardiac mast cells and subsequent MMP activation/collagen degradation during the acute stages of volume overload are prevented by blockade of the ETA receptor subtype. Furthermore, by preventing these events, ET-1 antagonism was efficacious in attenuating ventricular dilatation and limiting the development of structural and functional deficits.

endothelin-1; mast cell; matrix metalloproteinase; TBC-3214



Address for reprint requests and other correspondence: D. B. Murray, Univ. of Mississippi, School of Pharmacy, Dept. of Pharmacology, 219A Faser, Univ., MS 38677 (e-mail: dmurray{at}olemiss.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. J. Jobe, G. C. Melendez, S. P. Levick, Y. Du, G. L. Brower, and J. S. Janicki
TNF-{alpha} inhibition attenuates adverse myocardial remodeling in a rat model of volume overload
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1462 - H1468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.